Nurea

Nurea develops PREAVAorta®Suite integrating several medical devices (PRAEVAorta®2 is CE mark and FDA cleared), a unique and patented automated image analysis platform for diagnostic, surgery planning and follow-up of patients with cardiovascular diseases with a first focus on aortic aneurysms. The use of PRAEVAorta®Suite helps in extracting classical and advanced aortic measurements such as diameters or volume in a fully automated manner saving time and standardizing measurements. PRAEVAorta®2 can be easily integrated in PACS to streamline CT analysis.

Nurea has developed a unique system based on AI and advanced mathematical modeling that:

• automatized CT scan analysis providing reliable and relevant measurements to assess presence, morphology and growth of aortic aneurysms
• is the first solution being able to analyse contrasted and non contrasted CTs
• automatically generate branded sizing sheets to support device companies sales reps and/or clinical specialist teams
• provides a platform to automatically aggregate quantitative data for post market studies

PRAEVAorta®2 has been extensively validated by several top clinical teams on aortic aneurysms through scientific publications. It is now used in clinical routine in Europe and being deployed in 5 top centers in the US.